Countering counterfeits

Last year 125 people died in Pakistan after taking contaminated cardiac medication. The disaster is one example of the dangers of counterfeit and substandard medicines, an issue the WHO is struggling to control.

In this podcast we hear from Amir Attaran, Canada research chair in law, population health, and global development policy at the University of Ottawa, on the international wrangling he sees at the political level. And Sania Nishtar, president of Heartfile, an independent think tank based in India, discusses what went wrong in Pakistan, and how to prevent it happening again.

See also:
How to achieve international action on falsified and substandard medicines

Demo video

Audio chapters:

International action on falsified and substandard medicines: 0:40

The Pakistan disaster: 10:38